Chemed Stock Price, News & Analysis (NYSE:CHE)

$235.21 0.45 (0.19 %)
(As of 12/12/2017 04:00 PM ET)
Previous Close$234.76
Today's Range$234.77 - $237.82
52-Week Range$152.01 - $251.00
Volume125,146 shs
Average Volume94,732 shs
Market Capitalization$3.81 billion
P/E Ratio29.39
Dividend Yield0.47%
Beta1.16

About Chemed (NYSE:CHE)

Chemed logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Healthcare Facilities & Services
Sub-IndustryHealth Care Services
SectorMedical
SymbolNYSE:CHE
CUSIP16359R10
Phone513-762-6690

Debt

Debt-to-Equity Ratio0.15%
Current Ratio0.50%
Quick Ratio0.48%

Price-To-Earnings

Trailing P/E Ratio29.39
Forward P/E Ratio49.73
P/E Growth5.05

Sales & Book Value

Annual Sales$1.58 billion
Price / Sales2.38
Cash Flow$9.31 per share
Price / Cash25.27
Book Value$32.30 per share
Price / Book7.28

Profitability

Trailing EPS$4.50
Net Income$108.74 million
Net Margins4.62%
Return on Equity27.69%
Return on Assets15.16%

Miscellaneous

Employees14,613
Outstanding Shares15,970,000

Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Friday, November 3rd. Shareholders of record on Monday, November 13th will be given a dividend of $0.28 per share on Monday, December 4th. This represents a $1.12 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date is Friday, November 10th. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed announced that its Board of Directors has approved a stock buyback plan on Monday, April 10th 2017, which allows the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to buy up to 3.3% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's leadership believes its shares are undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings results on Thursday, October, 26th. The company reported $2.15 earnings per share for the quarter, beating analysts' consensus estimates of $2.00 by $0.15. The company had revenue of $417.40 million for the quarter, compared to the consensus estimate of $414.34 million. Chemed had a net margin of 4.62% and a return on equity of 27.69%. The business's revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.73 EPS. View Chemed's Earnings History.

When will Chemed make its next earnings announcement?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, February, 21st 2018. View Earnings Estimates for Chemed.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY17 earnings guidance on Thursday, October, 26th. The company provided earnings per share (EPS) guidance of $8.35-$8.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $8.19.

Where is Chemed's stock going? Where will Chemed's stock price be in 2017?

3 brokers have issued 12-month price objectives for Chemed's shares. Their forecasts range from $225.00 to $232.00. On average, they anticipate Chemed's stock price to reach $228.50 in the next year. View Analyst Ratings for Chemed.

Who are some of Chemed's key competitors?

Who are Chemed's key executives?

Chemed's management team includes the folowing people:

  • George J. Walsh III, Independent Chairman of the Board (Age 71)
  • Kevin J. McNamara, President, Chief Executive Officer, Director (Age 63)
  • David Patrick Williams, Chief Financial Officer, Executive Vice President (Age 56)
  • Spencer S. Lee, Executive Vice President (Age 61)
  • Nicholas Michael Westfall, Executive Vice President (Age 38)
  • Michael D. Witzeman, Principal Accounting Officer, Controller (Age 46)
  • Thomas Charles Hutton, Director (Age 66)
  • Joel F. Gemunder, Independent Director (Age 77)
  • Patrick P. Grace, Independent Director (Age 61)
  • Walter L. Krebs, Independent Director (Age 84)

Who owns Chemed stock?

Chemed's stock is owned by many different of institutional and retail investors. Top institutional investors include Neuberger Berman Group LLC (6.20%), Riverbridge Partners LLC (3.54%), Gamco Investors INC. ET AL (3.30%), Fisher Asset Management LLC (3.10%), Van Berkom & Associates Inc. (2.47%) and Dimensional Fund Advisors LP (2.47%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.

Who sold Chemed stock? Who is selling Chemed stock?

Chemed's stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Schroder Investment Management Group, Boston Partners, Van Berkom & Associates Inc., Gamco Investors INC. ET AL, Neuberger Berman Group LLC, Seizert Capital Partners LLC and Bank of New York Mellon Corp. Company insiders that have sold Chemed company stock in the last year include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.

Who bought Chemed stock? Who is buying Chemed stock?

Chemed's stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Old Mutual Global Investors UK Ltd., APG Asset Management N.V., Shell Asset Management Co., Wells Fargo & Company MN, Russell Investments Group Ltd., Chicago Equity Partners LLC and Mutual of America Capital Management LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy Chemed stock?

Shares of Chemed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of Chemed stock can currently be purchased for approximately $235.21.

How big of a company is Chemed?

Chemed has a market capitalization of $3.81 billion and generates $1.58 billion in revenue each year. The company earns $108.74 million in net income (profit) each year or $4.50 on an earnings per share basis. Chemed employs 14,613 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


MarketBeat Community Rating for Chemed (CHE)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  116 (Vote Outperform)
Underperform Votes:  163 (Vote Underperform)
Total Votes:  279
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Chemed (NYSE:CHE) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.252.252.332.33
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $228.50$228.50$214.50$151.50
Price Target Upside: 2.63% upside2.63% upside8.67% upside7.13% upside

Chemed (NYSE:CHE) Consensus Price Target History

Price Target History for Chemed (NYSE:CHE)

Chemed (NYSE:CHE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/31/2017Royal Bank of CanadaBoost Price TargetPositive -> Sector Perform$232.00N/AView Rating Details
10/27/2017OppenheimerBoost Price TargetOutperform$220.00 -> $225.00N/AView Rating Details
10/27/2017KeyCorpReiterated RatingHoldN/AView Rating Details
8/13/2017National Bank FinancialUpgradeSector Perform Market Weight -> Outperform Market WeightN/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
(Data available from 12/12/2015 forward)

Earnings

Chemed (NYSE:CHE) Earnings History and Estimates Chart

Earnings by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE CHE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/13/2018$2.27N/AView Earnings Details
10/26/2017Q3 2017$2.00$2.15$414.34 million$417.40 millionViewN/AView Earnings Details
7/25/2017Q2 2017$1.89$2.15$407.56 million$415.06 millionViewN/AView Earnings Details
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
8/7/2014$0.32$0.30$319.70 million$310.06 millionViewN/AView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Chemed (NYSE:CHE) Earnings Estimates

2017 EPS Consensus Estimate: $7.83
2018 EPS Consensus Estimate: $8.61
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20172$1.97$2.02$2.00
Q4 20172$2.12$2.23$2.18
Q1 20181$1.95$1.95$1.95
Q2 20181$2.09$2.09$2.09
Q3 20181$2.14$2.14$2.14
Q4 20181$2.43$2.43$2.43
(Data provided by Zacks Investment Research)

Dividends

Chemed (NYSE:CHE) Dividend Information

Most Recent Dividend:12/4/2017
Annual Dividend:$1.12
Dividend Yield:0.48%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:24.89% (Trailing 12 Months of Earnings)
23.68% (Based on This Year's Estimates)
12.57% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE:CHE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/3/2017Quarterly$0.280.48%11/10/201711/13/201712/4/2017
9/22/2017Monthly$0.109/28/20179/29/201710/31/2017
8/23/2017Monthly$0.108/29/20178/31/20179/29/2017
8/4/2017quarterly$0.280.57%8/10/20178/14/20179/1/2017
7/21/2017Monthly$0.107/27/20177/31/20178/31/2017
6/22/2017Monthly$0.106/28/20176/30/20177/31/2017
5/15/2017Quarterly$0.260.51%5/23/20175/25/20176/14/2017
2/17/2017quarterly$0.260.59%2/23/20172/27/20173/20/2017
11/4/2016quarterly$0.260.76%11/9/201611/14/201612/5/2016
8/5/2016quarterly$0.260.72%8/11/20168/15/20169/2/2016
5/16/2016quarterly$0.240.76%5/24/20165/26/20166/15/2016
2/19/2016quarterly$0.240.75%2/25/20162/29/20163/21/2016
11/6/2015quarterly$0.240.63%11/12/201511/16/201512/7/2015
8/7/2015quarterly$0.240.63%8/13/20158/17/20159/4/2015
5/18/2015quarterly$0.220.71%5/26/20155/28/20156/17/2015
2/20/2015quarterly$0.220.77%2/26/20153/2/20153/23/2015
11/7/2014quarterly$0.220.81%11/13/201411/17/201412/8/2014
8/11/2014quarterly$0.220.88%8/14/20148/18/20149/13/2014
8/8/2014quarterly$0.228/14/20148/18/20149/3/2014
5/19/2014quarterly$0.200.91%5/27/20145/29/20146/18/2014
2/21/2014quarterly$0.200.94%2/27/20143/3/20143/24/2014
11/8/2013quarterly$0.201.13%11/14/201311/18/201312/9/2013
8/2/2013quarterly$0.201.1%8/8/20138/12/20139/3/2013
5/20/2013quarterly$0.181.05%5/28/20135/30/20136/19/2013
2/20/2013quarterly$0.180.92%2/28/20133/4/20133/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Chemed (NYSE CHE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.90%
Institutional Ownership Percentage: 97.75%
Insider Trades by Quarter for Chemed (NYSE:CHE)
Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Chemed (NYSE CHE) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/4/2017Michael D WitzemanVPSell1,000$250.00$250,000.00View SEC Filing  
11/29/2017David Patrick WilliamsInsiderSell11,000$241.28$2,654,080.00View SEC Filing  
11/27/2017Naomi C DallobVPSell950$240.38$228,361.00View SEC Filing  
11/22/2017Spencer S LeeInsiderSell1,000$238.24$238,240.00View SEC Filing  
11/16/2017Michael D WitzemanVPSell1,579$235.00$371,065.00View SEC Filing  
11/15/2017Kevin J McnamaraCEOSell5,000$232.59$1,162,950.00View SEC Filing  
11/15/2017Spencer S LeeInsiderSell1,000$232.27$232,270.00View SEC Filing  
11/13/2017Nicholas Michael WestfallInsiderSell10,000$231.00$2,310,000.00View SEC Filing  
11/8/2017Naomi C DallobVPSell1,900$231.00$438,900.00View SEC Filing  
11/2/2017Donald E SaundersDirectorSell500$227.75$113,875.00View SEC Filing  
11/2/2017Spencer S LeeEVPSell1,000$228.45$228,450.00View SEC Filing  
10/31/2017Kevin J McnamaraCEOSell10,000$223.42$2,234,200.00View SEC Filing  
10/31/2017Naomi C DallobVPSell750$222.09$166,567.50View SEC Filing  
10/2/2017Patrick P GraceDirectorSell500$201.48$100,740.00View SEC Filing  
9/1/2017Spencer S LeeInsiderSell1,000$197.46$197,460.00View SEC Filing  
7/28/2017Kevin J McnamaraInsiderSell15,000$201.16$3,017,400.00View SEC Filing  
6/26/2017George J Walsh IIIDirectorBuy1,000$204.56$204,560.00View SEC Filing  
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.46View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.00View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.00View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.00View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.38View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Chemed (NYSE CHE) News Headlines

Source:
DateHeadline
DaVita (DVA) Surges: Stock Moves 13.6% HigherDaVita (DVA) Surges: Stock Moves 13.6% Higher
www.zacks.com - December 7 at 9:24 AM
Chemed Banks on Roto-Rooter Sales, Focuses on Vitas RevivalChemed Banks on Roto-Rooter Sales, Focuses on Vitas Revival
finance.yahoo.com - December 7 at 9:24 AM
Align Technology Rides High on InvisAlign & Strategic PactsAlign Technology Rides High on InvisAlign & Strategic Pacts
finance.yahoo.com - December 6 at 9:29 AM
Chemed Corp. (CHE) VP Michael D. Witzeman Sells 1,000 SharesChemed Corp. (CHE) VP Michael D. Witzeman Sells 1,000 Shares
www.americanbankingnews.com - December 4 at 11:42 AM
Zacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural ResourcesZacks.com highlights: Chemed, Baxter International, IDEXX Laboratories, Advanced Energy Industries and Pioneer Natural Resources
finance.yahoo.com - December 4 at 9:15 AM
Chemed (CHE) Rating Lowered to Hold at ValuEngineChemed (CHE) Rating Lowered to Hold at ValuEngine
www.americanbankingnews.com - December 3 at 7:58 PM
Financial Contrast: Chemed (CHE) and Laboratory Corporation of America (LH)Financial Contrast: Chemed (CHE) and Laboratory Corporation of America (LH)
www.americanbankingnews.com - December 3 at 1:24 AM
Heres Why You Should Add Chemed (CHE) to Your Portfolio NowHere's Why You Should Add Chemed (CHE) to Your Portfolio Now
finance.yahoo.com - December 1 at 4:42 PM
Here's Why You Should Add Chemed (CHE) to Your Portfolio NowHere's Why You Should Add Chemed (CHE) to Your Portfolio Now
finance.yahoo.com - December 1 at 4:42 PM
Insider Selling: Chemed Corp. (CHE) Insider Sells 11,000 Shares of StockInsider Selling: Chemed Corp. (CHE) Insider Sells 11,000 Shares of Stock
www.americanbankingnews.com - November 30 at 10:30 AM
Chemed (CHE) Up 13.6% Since Earnings Report: Can It Continue?Chemed (CHE) Up 13.6% Since Earnings Report: Can It Continue?
finance.yahoo.com - November 28 at 4:49 PM
Chemed Corp. (CHE) Receives Consensus Recommendation of "Hold" from AnalystsChemed Corp. (CHE) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 28 at 1:36 AM
Chemed Corp. (CHE) VP Naomi C. Dallob Sells 950 SharesChemed Corp. (CHE) VP Naomi C. Dallob Sells 950 Shares
www.americanbankingnews.com - November 27 at 1:36 PM
$423.56 Million in Sales Expected for Chemed Corp. (CHE) This Quarter$423.56 Million in Sales Expected for Chemed Corp. (CHE) This Quarter
www.americanbankingnews.com - November 27 at 4:36 AM
 Brokerages Anticipate Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share Brokerages Anticipate Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share
www.americanbankingnews.com - November 25 at 7:12 PM
Chemed Corp. (CHE) Insider Sells $238,240.00 in StockChemed Corp. (CHE) Insider Sells $238,240.00 in Stock
www.americanbankingnews.com - November 22 at 2:02 PM
Insider Selling: Chemed Corp. (CHE) VP Sells 1,579 Shares of StockInsider Selling: Chemed Corp. (CHE) VP Sells 1,579 Shares of Stock
www.americanbankingnews.com - November 17 at 1:48 PM
Chemed Corp. (CHE) Insider Sells $232,270.00 in StockChemed Corp. (CHE) Insider Sells $232,270.00 in Stock
www.americanbankingnews.com - November 16 at 4:48 PM
Kevin J. Mcnamara Sells 5,000 Shares of Chemed Corp. (CHE) StockKevin J. Mcnamara Sells 5,000 Shares of Chemed Corp. (CHE) Stock
www.americanbankingnews.com - November 16 at 4:22 PM
ETFs with exposure to Chemed Corp. : November 14, 2017ETFs with exposure to Chemed Corp. : November 14, 2017
finance.yahoo.com - November 14 at 5:41 PM
Chemed Corp. (CHE) Insider Sells $2,310,000.00 in StockChemed Corp. (CHE) Insider Sells $2,310,000.00 in Stock
www.americanbankingnews.com - November 14 at 1:32 PM
Head to Head Comparison: Chemed Corp. (CHE) and The Joint Corp. (JYNT)Head to Head Comparison: Chemed Corp. (CHE) and The Joint Corp. (JYNT)
www.americanbankingnews.com - November 9 at 10:26 AM
Chemed Corp. (CHE) VP Naomi C. Dallob Sells 1,900 SharesChemed Corp. (CHE) VP Naomi C. Dallob Sells 1,900 Shares
www.americanbankingnews.com - November 8 at 12:40 PM
Zacks: Analysts Expect Chemed Corp. (CHE) Will Post Quarterly Sales of $423.56 MillionZacks: Analysts Expect Chemed Corp. (CHE) Will Post Quarterly Sales of $423.56 Million
www.americanbankingnews.com - November 8 at 2:06 AM
 Analysts Expect Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share Analysts Expect Chemed Corp. (CHE) Will Post Earnings of $2.28 Per Share
www.americanbankingnews.com - November 6 at 11:26 PM
Insider Selling: Chemed Corp. (CHE) Director Sells 500 Shares of StockInsider Selling: Chemed Corp. (CHE) Director Sells 500 Shares of Stock
www.americanbankingnews.com - November 6 at 3:34 PM
Chemed Corp. to Issue Dividend of $0.28 (CHE)Chemed Corp. to Issue Dividend of $0.28 (CHE)
www.americanbankingnews.com - November 4 at 10:56 AM
Chemed Corporation Declares Quarterly Dividend of 28 CentsChemed Corporation Declares Quarterly Dividend of 28 Cents
finance.yahoo.com - November 4 at 7:40 AM
Insider Selling: Chemed Corp. (CHE) EVP Sells 1,000 Shares of StockInsider Selling: Chemed Corp. (CHE) EVP Sells 1,000 Shares of Stock
www.americanbankingnews.com - November 3 at 2:44 PM
Chemed Corp. (CHE) Given Consensus Recommendation of "Hold" by BrokeragesChemed Corp. (CHE) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 3 at 5:46 AM
ETFs with exposure to Chemed Corp. : November 2, 2017ETFs with exposure to Chemed Corp. : November 2, 2017
finance.yahoo.com - November 2 at 6:00 PM
Zacks Investment Research Upgrades Chemed Corp. (CHE) to "Buy"Zacks Investment Research Upgrades Chemed Corp. (CHE) to "Buy"
www.americanbankingnews.com - November 2 at 2:20 PM
KeyCorp Weighs in on Chemed Corp.s FY2017 Earnings (CHE)KeyCorp Weighs in on Chemed Corp.'s FY2017 Earnings (CHE)
www.americanbankingnews.com - November 2 at 9:28 AM
Chemed Corp. :CHE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Chemed Corp. :CHE-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 5:54 PM
Chemed Corp. (CHE) VP Sells $166,567.50 in StockChemed Corp. (CHE) VP Sells $166,567.50 in Stock
www.americanbankingnews.com - November 1 at 2:44 PM
Kevin J. Mcnamara Sells 10,000 Shares of Chemed Corp. (CHE) StockKevin J. Mcnamara Sells 10,000 Shares of Chemed Corp. (CHE) Stock
www.americanbankingnews.com - November 1 at 2:44 PM
KeyCorp Equities Analysts Increase Earnings Estimates for Chemed Corp. (CHE)KeyCorp Equities Analysts Increase Earnings Estimates for Chemed Corp. (CHE)
www.americanbankingnews.com - November 1 at 12:00 PM
BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013BRIEF-Chemed reaches final agreement to end civil litigation & false claims act brought by U.S. DOJ in May 2013
www.reuters.com - October 31 at 6:19 PM
Chemed Settles DOJ LitigationChemed Settles DOJ Litigation
finance.yahoo.com - October 31 at 6:19 PM
One of Cincinnatis largest public companies agrees to $75M settlement with fedsOne of Cincinnati's largest public companies agrees to $75M settlement with feds
finance.yahoo.com - October 31 at 6:19 PM
Chemed to pay $75 mln over false claims lawsuit -Justice DeptChemed to pay $75 mln over false claims lawsuit -Justice Dept
finance.yahoo.com - October 31 at 1:51 AM
Chemed to pay $75 million over false claims lawsuit: Justice DeptChemed to pay $75 million over false claims lawsuit: Justice Dept
www.reuters.com - October 30 at 8:50 PM
Stocks Showing Market Leadership: Chemed Earns 90 RS RatingStocks Showing Market Leadership: Chemed Earns 90 RS Rating
finance.yahoo.com - October 30 at 3:49 PM
Chemed Corporation (CHE) CEO Kevin McNamara Q3 2017 Results - Earnings Call TranscriptChemed Corporation (CHE) CEO Kevin McNamara Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - October 28 at 10:28 PM
Oppenheimer Holdings, Inc. Increases Chemed Corp. (CHE) Price Target to $225.00Oppenheimer Holdings, Inc. Increases Chemed Corp. (CHE) Price Target to $225.00
www.americanbankingnews.com - October 28 at 3:34 PM
Edited Transcript of CHE earnings conference call or presentation 27-Oct-17 2:00pm GMTEdited Transcript of CHE earnings conference call or presentation 27-Oct-17 2:00pm GMT
finance.yahoo.com - October 28 at 12:51 AM
Chemed Corporation to Host Earnings CallChemed Corporation to Host Earnings Call
finance.yahoo.com - October 27 at 7:51 PM
Chemed Corp. (CHE) Posts  Earnings Results, Beats Expectations By $0.15 EPSChemed Corp. (CHE) Posts Earnings Results, Beats Expectations By $0.15 EPS
www.americanbankingnews.com - October 26 at 6:30 PM
BRIEF-Chemed reports Q3 earnings per share $2.13BRIEF-Chemed reports Q3 earnings per share $2.13
www.reuters.com - October 26 at 5:24 PM
How Do Analysts See Chemed Corporation (CHE) Performing In The Year Ahead?How Do Analysts See Chemed Corporation (CHE) Performing In The Year Ahead?
finance.yahoo.com - October 26 at 5:24 PM

SEC Filings

Chemed (NYSE:CHE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Chemed (NYSE:CHE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Chemed (NYSE CHE) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.